Sunday, August 16, 2020 2:51:24 PM
Psilocybin will be on the frontline in the battles against addiction, depression and mental health.
It has growth potential in the tens of billions.
And Revive is way ahead of the game.
https://revivethera.com/2020/08/revive-therapeutics-advancing-drug-delivery-technology-for-psychedelics-developed-prototypes-of-orally-dissolvable-thin-film-for-psilocybin/
It has growth potential in the tens of billions.
And Revive is way ahead of the game.
https://revivethera.com/2020/08/revive-therapeutics-advancing-drug-delivery-technology-for-psychedelics-developed-prototypes-of-orally-dissolvable-thin-film-for-psilocybin/
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
